Skip to main content
. 2007 Apr 5;56(11):1723–1731. doi: 10.1007/s00262-007-0316-1

Fig. 1.

Fig. 1

Differential expression of NY-BR-1, estrogen receptor (ER), EGFR and HLA class I heavy chain in breast carcinoma lesions by immunohistochemistry using mAbs. The staining for NY-BR-1 was nuclear/cytoplasmic, for ER nuclear, for EGFR membraneous/cytoplasmic and for HLA class I predominantly membranous. Only stromal and inflammatory cells were stained in negative tumor lesions